IP Library Granted Patent US 12,636,499
Granted Patent B2
US 12,636,499 · App. 18/587,764 · Granted May 26, 2026

Sensor-based pain management systems and methods

Inventors: Kyle Harish Srivastava (Saint Paul, MN); Pramodsingh Hirasingh Thakur (Woodbury, MN); Dat Thanh Huynh (North Hollywood, CA); Bryan Allen Clark (Forest Lake, MN); Jianwen Gu (Richmond, TX)
Assignee: Boston Scientific Neuromodulation Corporation
A61N1/36139A61B5/1118A61B5/6801A61N1/36071A61B5/01A61B5/02028A61B5/021A61B5/024A61B5/02416A61B5/0533A61B5/0816A61B5/1112A61B5/1116A61B5/112A61B5/1121A61B5/318A61B5/369A61B5/389A61B5/4806A61B5/4824A61B2562/0219A61B2562/0223A61B2562/0261A61N1/0529A61N1/0551A61N1/36053A61N1/36057A61N1/36062
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,636,499
App. No.
18/587,764
Granted
May 26, 2026
Kind
B2
Abstract

This document discusses, among other things, systems and methods for managing pain of a subject. A system includes a first sensor circuit to sense a first signal indicative of a functional state of the subject, a second sensor circuit to sense a second signal different from the first signal, and a controller circuit. The controller circuit may determine an operating mode of the second sensor circuit according to the sensed first signal, trigger the second senor circuit to sense the second signal under the determined operating mode, and generate a pain score using at least the second signal sensed under the determined operating mode. The pain score may be output to a patient or used for closed-loop control of a pain therapy.

Claims (52)

1 . A neuromodulation system, comprising:

a sensor circuit, including a physiological sensor configured to sense a physiological signal from a patient, and a motion sensor configured to detect a physical activity pattern of the patient representing a change in physical activity over time; and

a controller circuit configured to:

determine a dissimilarity between the detected physical activity pattern and a baseline physical activity pattern at a baseline state of the patient, the dissimilarity indicative of a change in activity from the baseline state;

determine or adjust a data acquisition protocol including one or more of a duration, a data rate, or a data resolution for collecting data from the physiological signal sensed by the physiological sensor based on the determined dissimilarity, including (i) increasing one or more of the data rate, the data resolution, or the data acquisition duration in response to the dissimilarity exceeding a threshold indicative of a decrease in activity from the baseline state, and (ii) decreasing one or more of the data rate, the data resolution, or the data acquisition duration in response to the dissimilarity falling below the threshold indicative of an increase in activity from the baseline state; and

initiate or adjust a neuromodulation therapy to the patient based at least in part on an analysis of the data collected from the sensed physiological signal in accordance with the determined or adjusted data acquisition protocol.

2 . The neuromodulation system of claim 1 , wherein the data acquisition protocol includes a sampling rate for sampling the sensed physiological signal,

wherein the controller circuit is configured to initiate or adjust the neuromodulation therapy based at least in part on the analysis of the data collected from the sensed physiological signal at the determined or adjusted sampling rate.

3 . The neuromodulation system of claim 2 , wherein the baseline physical activity pattern includes a baseline activity level, and the detected physical activity pattern includes a detected activity level,

wherein the controller circuit is configured to increase the sampling rate when the detected activity level falls below the baseline activity level by a first threshold, and to decrease the sampling rate when the detected activity level exceeds the baseline activity level by a second threshold.

4 . The neuromodulation system of claim 2 , wherein the baseline physical activity pattern includes a baseline rate of change in activity level during a specific time of a day, and the detected physical activity pattern includes a detected rate of change in activity level during the specific time of a day;

wherein the controller circuit is configured to increase the sampling rate when the detected rate of change in activity level falls below the baseline rate of change in activity level by a first threshold, and to decrease the sampling rate when the detected rate of change in activity level exceeds the baseline rate of change in activity level by a second threshold.

5 . The neuromodulation system of claim 1 , wherein the data acquisition protocol includes timing for collecting data from the sensed physiological signal,

wherein the controller circuit is configured to initiate or adjust the neuromodulation therapy based at least in part on the analysis of the data collected from the sensed physiological signal at the determined or adjusted timing.

6 . The neuromodulation system of claim 5 , wherein the timing for collecting the data from the sensed physiological signal includes one or more of a time to initiate the data collection or a duration for sampling data from the sensed physiological signal.

7 . The neuromodulation system of claim 6 , wherein the baseline physical activity pattern includes a baseline activity level, and the detected physical activity pattern includes a detected activity level,

wherein the controller circuit is configured to increase the sampling duration when the detected activity level falls below the baseline activity level by a first threshold, and to decrease the sampling duration when the detected activity level exceeds the baseline activity level by a second threshold.

8 . The neuromodulation system of claim 1 , wherein the data acquisition protocol includes a digitization resolution for digitizing the sensed physiological signal,

wherein the controller circuit is configured to initiate or adjust the neuromodulation therapy based at least in part on the analysis of the digitized physiological signal at the determined or adjusted digitization resolution.

9 . The neuromodulation system of claim 8 , wherein the baseline physical activity pattern includes a baseline activity level, and the detected physical activity pattern includes a detected activity level,

wherein the controller circuit is configured to increase the digitization resolution when the detected activity level falls below the baseline activity level by a first threshold, and to decrease the digitization resolution when the detected activity level exceeds the baseline activity level by a second threshold.

10 . The neuromodulation system of claim 1 , wherein the baseline physical activity pattern corresponds to a baseline state free of pain, and wherein the controller circuit is configured to:

determine a pain score using the data collected from the sensed physiological signal in accordance with the determined or adjusted data acquisition protocol; and

initiate or adjust the neuromodulation therapy based at least in part on the determined pain score to alleviate pain.

11 . The neuromodulation system of claim 1 , wherein the baseline physical activity pattern includes a scheduled activity at a specific time of a day,

wherein the controller circuit is configured to determine or adjust the data acquisition protocol based on the determined dissimilarity indicating whether or not the scheduled activity is missing from the detected physical activity at the specific time of a day.

12 . The neuromodulation system of claim 11 , wherein to determine or adjust the data acquisition protocol, the controller circuit is configured to:

increase one or more of a sampling rate, a sampling duration, or a digitization resolution for sampling the sensed physiological signal when the scheduled activity is absent from the detected physical activity at the specific time of a day; and

decrease one or more of the sampling rate, the sampling duration, or the digitization resolution for sampling the sensed physiological signal when the scheduled activity is present in the detected physical activity at the specific time of a day.

13 . A method of operating a neuromodulation system to provide neuromodulation to a patient, the method comprising:

determining a baseline physical activity pattern at a baseline state of the patient;

detecting a physical activity pattern of the patient using a motion sensor, the physical activity pattern representing a change in physical activity over time;

sensing a physiological signal from the patient using a physiological sensor;

determining a dissimilarity between the detected physical activity pattern and the baseline physical activity pattern, the dissimilarity indicative of a change in activity from the baseline state;

based on the determined dissimilarity, determining or adjusting a data acquisition protocol including one or more of a duration, a data rate, or a data resolution for collecting data from the physiological signal sensed by the physiological sensor using a controller circuit, including (i) increasing one or more of the data rate, the data resolution, or the data acquisition duration in response to the dissimilarity exceeding a threshold indicative of a decrease in activity from the baseline state, and (ii) decreasing one or more of the data rate, the data resolution, or the data acquisition duration in response to the dissimilarity falling below the threshold indicative of an increase in activity from the baseline state; and

via the controller circuit, initiating or adjusting a neuromodulation therapy based at least in part on an analysis of the data collected from the sensed physiological signal in accordance with the determined or adjusted data acquisition protocol.

14 . The method of claim 13 , wherein the data acquisition protocol includes a sampling rate for sampling the sensed physiological signal,

wherein initiating or adjusting the neuromodulation therapy is based at least in part on the analysis of the data collected from the sensed physiological signal at the determined or adjusted sampling rate.

15 . The method of claim 14 , wherein the baseline physical activity pattern includes a baseline activity level, and the detected physical activity pattern includes a detected activity level,

wherein determining or adjusting the data acquisition protocol includes increasing the sampling rate when the detected activity level falls below the baseline activity level by a first threshold, and decreasing the sampling rate when the detected activity level exceeds the baseline activity level by a second threshold.

16 . The method of claim 13 , wherein the data acquisition protocol includes timing for collecting data from the sensed physiological signal,

wherein initiating or adjusting the neuromodulation therapy is based at least in part on the analysis of the data collected from the sensed physiological signal at the determined or adjusted timing.

17 . The method of claim 16 , wherein the baseline physical activity pattern includes a baseline activity level, and the detected physical activity pattern includes a detected activity level,

wherein determining or adjusting the data acquisition protocol includes increasing a sampling duration for sampling the sensed physiological signal when the detected activity level falls below the baseline activity level by a first threshold, and decreasing the sampling duration when the detected activity level exceeds the baseline activity level by a second threshold.

18 . The method of claim 13 , wherein the data acquisition protocol includes a digitization resolution for digitizing the sensed physiological signal,

wherein initiating or adjusting the neuromodulation therapy is based at least in part on the analysis of the digitized physiological signal at the determined or adjusted digitization resolution.

19 . The method of claim 13 , wherein the baseline physical activity pattern corresponds to a baseline state free of pain, the method further includes determining a pain score using the data collected from the sensed physiological signal in accordance with the determined or adjusted data acquisition protocol,

wherein initiating or adjusting the neuromodulation therapy is based at least in part on the determined pain score to alleviate pain.

20 . The method of claim 13 , wherein the baseline physical activity pattern includes a scheduled activity at a specific time of a day,

wherein determining or adjusting the data acquisition protocol includes:

increasing one or more of a sampling rate, a sampling duration, or a digitization resolution for sampling the sensed physiological signal when the scheduled activity is absent from the detected physical activity at the specific time of a day; and

decreasing one or more of the sampling rate, the sampling duration, or the digitization resolution for sampling the sensed physiological signal when the scheduled activity is present in the detected physical activity at the specific time of a day.

Continuity (5)
Continuation 17884794 · Aug 10, 2022
Continuation 17095642 · Nov 11, 2020
Continuation 16034304 · Jul 12, 2018
Provisional Application 62533789 · Jul 18, 2017
Related Publication 20240198112A1 · Jun 20, 2024
References Cited (400)
US 4297685A · Brainard, II · 1981 [cited by applicant]
US 5187675A · Dent et al. · 1993 [cited by applicant]
US 5774591A · Black et al. · 1998 [cited by applicant]
US 6016103A · Leavitt · 2000 [cited by applicant]
US 6076011A · Hoover · 2000 [cited by applicant]
US 6088040A · Oda et al. · 2000 [cited by applicant]
US 6173260B1 · Slaney · 2001 [cited by applicant]
US 6480734B1 · Zhang et al. · 2002 [cited by applicant]
US 6497658B2 · Roizen et al. · 2002 [cited by applicant]
US 6654632B2 · Lange et al. · 2003 [cited by applicant]
US 6659968B1 · McClure · 2003 [cited by applicant]
US 6731984B2 · Cho et al. · 2004 [cited by applicant]
US 6871099B1 · Whitehurst et al. · 2005 [cited by applicant]
US 7001337B2 · Dekker · 2006 [cited by applicant]
US 7004907B2 · Banet et al. · 2006 [cited by applicant]
US 7177686B1 · Turcott · 2007 [cited by applicant]
US 7189204B2 · Ni et al. · 2007 [cited by applicant]
US 7222075B2 · Petrushin · 2007 [cited by applicant]
US 7299086B2 · McCabe et al. · 2007 [cited by applicant]
US 7376457B2 · Ross · 2008 [cited by applicant]
US 7407485B2 · Huiku · 2008 [cited by applicant]
US 7463927B1 · Chaouat · 2008 [cited by applicant]
US 7566308B2 · Stahmann · 2009 [cited by applicant]
US 7627475B2 · Petrushin · 2009 [cited by applicant]
US 7636602B2 · Baru Fassio et al. · 2009 [cited by applicant]
US 7650184B2 · Walter · 2010 [cited by applicant]
US 7678061B2 · Lee et al. · 2010 [cited by applicant]
US 7775993B2 · Heruth et al. · 2010 [cited by applicant]
US 7957809B2 · Bourget et al. · 2011 [cited by applicant]
US 7986991B2 · Prichep · 2011 [cited by applicant]
US 8019439B2 · Kuzma et al. · 2011 [cited by applicant]
US 8055348B2 · Heruth et al. · 2011 [cited by applicant]
US 8083682B2 · Dalal et al. · 2011 [cited by applicant]
US 8192376B2 · Lovett et al. · 2012 [cited by applicant]
US 8209182B2 · Narayanan · 2012 [cited by applicant]
US 8290596B2 · Wei et al. · 2012 [cited by applicant]
US 8332038B2 · Heruth et al. · 2012 [cited by applicant]
US 8398556B2 · Sethi et al. · 2013 [cited by applicant]
US 8447401B2 · Miesel et al. · 2013 [cited by applicant]
US 8475370B2 · McCombie et al. · 2013 [cited by applicant]
US 8529459B2 · Malker et al. · 2013 [cited by applicant]
US 8606356B2 · Lee et al. · 2013 [cited by applicant]
US 8688221B2 · Miesel · 2014 [cited by applicant]
US 8744587B2 · Miesel et al. · 2014 [cited by applicant]
US 8805518B2 · King et al. · 2014 [cited by applicant]
US 9066659B2 · Thakur et al. · 2015 [cited by applicant]
US 9072870B2 · Wu et al. · 2015 [cited by applicant]
US 9119965B2 · Xi et al. · 2015 [cited by applicant]
US 9314168B2 · Watson et al. · 2016 [cited by applicant]
US 9395792B1 · Kahn et al. · 2016 [cited by applicant]
US 10349212B2 · Tartz et al. · 2019 [cited by applicant]
US 10610688B2 · Thakur et al. · 2020 [cited by applicant]
US 10631776B2 · Annoni et al. · 2020 [cited by applicant]
US 10631777B2 · Clark et al. · 2020 [cited by applicant]
US 10667747B2 · Annoni et al. · 2020 [cited by applicant]
US 10675469B2 · Annoni et al. · 2020 [cited by applicant]
US 10729905B2 · Annoni et al. · 2020 [cited by applicant]
US 10750994B2 · Annoni et al. · 2020 [cited by applicant]
US 10898718B2 · Srivastava · 2021 [cited by examiner]
US 10926091B2 · Srivastava et al. · 2021 [cited by applicant]
US 10960210B2 · Srivastava et al. · 2021 [cited by applicant]
US 11089997B2 · Annoni et al. · 2021 [cited by applicant]
US 11337646B2 · Annoni et al. · 2022 [cited by applicant]
US 11395625B2 · Clark et al. · 2022 [cited by applicant]
US 11439827B2 · Srivastava · 2022 [cited by examiner]
US 11446499B2 · Thakur et al. · 2022 [cited by applicant]
US 11541240B2 · Annoni et al. · 2023 [cited by applicant]
US 11571577B2 · Srivastava et al. · 2023 [cited by applicant]
US 11691014B2 · Srivastava et al. · 2023 [cited by applicant]
US 11751804B2 · Annoni et al. · 2023 [cited by applicant]
US 11957912B2 · Srivastava · 2024 [cited by examiner]
US 20010037222A1 · Platt et al. · 2001 [cited by applicant]
US 20020042563A1 · Becerra et al. · 2002 [cited by applicant]
US 20040015091A1 · Greenwald et al. · 2004 [cited by applicant]
US 20050010262A1 · Sharan et al. · 2005 [cited by applicant]
US 20050209643A1 · Heruth et al. · 2005 [cited by applicant]
US 20070167859A1 · Finneran et al. · 2007 [cited by applicant]
US 20070213783A1 · Pless · 2007 [cited by applicant]
US 20070260285A1 · Libbus et al. · 2007 [cited by applicant]
US 20080015659A1 · Zhang et al. · 2008 [cited by applicant]
US 20080077192A1 · Harry et al. · 2008 [cited by applicant]
US 20080177191A1 · Patangay et al. · 2008 [cited by applicant]
US 20080249430A1 · John et al. · 2008 [cited by applicant]
US 20090124863A1 · Liu et al. · 2009 [cited by applicant]
US 20090192556A1 · Wu et al. · 2009 [cited by applicant]
US 20090312663A1 · John et al. · 2009 [cited by applicant]
US 20090318986A1 · Alo et al. · 2009 [cited by applicant]
US 20100016913A1 · Arcot-Krishnamurthy et al. · 2010 [cited by applicant]
US 20100105997A1 · Ecker et al. · 2010 [cited by applicant]
US 20100191311A1 · Scheiner et al. · 2010 [cited by applicant]
US 20100286549A1 · John et al. · 2010 [cited by applicant]
US 20110015702A1 · Ternes et al. · 2011 [cited by applicant]
US 20110021928A1 · Giovangrandi et al. · 2011 [cited by applicant]
US 20110034760A1 · Brynelsen et al. · 2011 [cited by applicant]
US 20110112420A1 · Nagata et al. · 2011 [cited by applicant]
US 20110124979A1 · Heneghan et al. · 2011 [cited by applicant]
US 20110137134A1 · Hemmerling et al. · 2011 [cited by applicant]
US 20110172562A1 · Sahasrabudhe et al. · 2011 [cited by applicant]
US 20110224749A1 · Ben-David et al. · 2011 [cited by applicant]
US 20110306846A1 · Osorio · 2011 [cited by applicant]
US 20120046715A1 · Moffitt et al. · 2012 [cited by applicant]
US 20120109012A1 · Cinbis · 2012 [cited by applicant]
US 20120150545A1 · Simon · 2012 [cited by applicant]
US 20120277818A1 · Stancer et al. · 2012 [cited by applicant]
US 20130066394A1 · Saab · 2013 [cited by applicant]
US 20130165994A1 · Ternes et al. · 2013 [cited by applicant]
US 20130211291A1 · Tran · 2013 [cited by applicant]
US 20130268016A1 · Xi et al. · 2013 [cited by applicant]
US 20140276188A1 · Jardin · 2014 [cited by applicant]
US 20140276549A1 · Osorio · 2014 [cited by applicant]
US 20140277240A1 · Maskara · 2014 [cited by examiner]
US 20140309709A1 · Gozani et al. · 2014 [cited by applicant]
US 20150005842A1 · Lee et al. · 2015 [cited by applicant]
US 20150025335A1 · Jain et al. · 2015 [cited by applicant]
US 20150148878A1 · Yoo et al. · 2015 [cited by applicant]
US 20150289803A1 · Wu et al. · 2015 [cited by applicant]
US 20160022203A1 · Arnold et al. · 2016 [cited by applicant]
US 20160082265A1 · Moffitt et al. · 2016 [cited by applicant]
US 20160129272A1 · Hou et al. · 2016 [cited by applicant]
US 20160144194A1 · Roothans et al. · 2016 [cited by applicant]
US 20160158551A1 · Kent et al. · 2016 [cited by applicant]
US 20160192890A1 · Averina · 2016 [cited by examiner]
US 20160198996A1 · Dullen · 2016 [cited by applicant]
US 20160243359A1 · Sharma · 2016 [cited by applicant]
US 20160302720A1 · John et al. · 2016 [cited by applicant]
US 20160350509A1 · Sharma · 2016 [cited by applicant]
US 20160361515A1 · Jung et al. · 2016 [cited by applicant]
US 20160374567A1 · Breslow et al. · 2016 [cited by applicant]
US 20170128722A1 · Perez · 2017 [cited by applicant]
US 20170136264A1 · Hyde et al. · 2017 [cited by applicant]
US 20170164876A1 · Hyde et al. · 2017 [cited by applicant]
US 20170165485A1 · Sullivan et al. · 2017 [cited by applicant]
US 20170231568A1 · An · 2017 [cited by examiner]
US 20180078768A1 · Thakur et al. · 2018 [cited by applicant]
US 20180085055A1 · Annoni et al. · 2018 [cited by applicant]
US 20180085584A1 · Thakur et al. · 2018 [cited by applicant]
US 20180110464A1 · Annoni et al. · 2018 [cited by applicant]
US 20180126169A1 · Hou et al. · 2018 [cited by applicant]
US 20180192941A1 · Annoni et al. · 2018 [cited by applicant]
US 20180192942A1 · Clark et al. · 2018 [cited by applicant]
US 20180192943A1 · Annoni et al. · 2018 [cited by applicant]
US 20180193644A1 · Annoni et al. · 2018 [cited by applicant]
US 20180193650A1 · Srivastava et al. · 2018 [cited by applicant]
US 20180193651A1 · Annoni et al. · 2018 [cited by applicant]
US 20180193652A1 · Srivastava et al. · 2018 [cited by applicant]
US 20180229040A1 · Srivastava et al. · 2018 [cited by applicant]
US 20190022397A1 · Srivastava et al. · 2019 [cited by applicant]
US 20200188673A1 · Thakur et al. · 2020 [cited by applicant]
US 20200214623A1 · Annoni et al. · 2020 [cited by applicant]
US 20200214624A1 · Clark et al. · 2020 [cited by applicant]
US 20200238087A1 · Annoni et al. · 2020 [cited by applicant]
US 20200359960A1 · Annoni et al. · 2020 [cited by applicant]
US 20210060343A1 · Srivastava et al. · 2021 [cited by applicant]
US 20210128921A1 · Srivastava et al. · 2021 [cited by applicant]
US 20210178164A1 · Srivastava et al. · 2021 [cited by applicant]
US 20210345950A1 · Annoni et al. · 2021 [cited by applicant]
US 20220323760A1 · Thakur et al. · 2022 [cited by applicant]
US 20220379119A1 · Srivastava et al. · 2022 [cited by applicant]
US 20220401739A1 · Srivastava · 2022 [cited by examiner]
US 20230103448A1 · Annoni et al. · 2023 [cited by applicant]
US 20230120858A1 · Srivastava et al. · 2023 [cited by applicant]
AU 2017335497B2 · 2020 [cited by applicant]
AU 2017334841B2 · 2020 [cited by applicant]
AU 2018304079B2 · 2020 [cited by applicant]
EP 1059064A2 · 2000 [cited by applicant]
EP 1897586A1 · 2008 [cited by applicant]
EP 3519037B1 · 2020 [cited by applicant]
EP 3568069B1 · 2021 [cited by applicant]
EP 3518736B1 · 2021 [cited by applicant]
KR 20050053824A · 2005 [cited by applicant]
KR 1020050053824A · 2005 [cited by applicant]
RU 2559783C1 · 2015 [cited by applicant]
WO WO2007007058A1 · 2007 [cited by applicant]
WO WO2009055127A1 · 2009 [cited by applicant]
WO WO2010051406A1 · 2010 [cited by applicant]
WO WO2011008747A2 · 2011 [cited by applicant]
WO WO2011053607A1 · 2011 [cited by applicant]
WO WO2013134479A1 · 2013 [cited by applicant]
WO WO2014151860A1 · 2014 [cited by applicant]
WO WO2015060888A1 · 2015 [cited by applicant]
WO WO2015128567 · 2015 [cited by applicant]
WO WO2016025989A1 · 2016 [cited by applicant]
WO WO2016077786A1 · 2016 [cited by applicant]
WO WO2018052695A1 · 2018 [cited by applicant]
WO WO2018063637A1 · 2018 [cited by applicant]
WO WO2018063912A1 · 2018 [cited by applicant]
WO WO2018080887A1 · 2018 [cited by applicant]
WO WO2019018206A1 · 2019 [cited by applicant]
“2015 Sleep in America® Poll Sleep and Pain—Summary of Findings”, National Sleep Foundation, (2015), 1-54. [cited by applicant]
“U.S. Appl. No. 15/687,925, Final Office Action mailed Feb. 14, 2019”, 10 pgs. [cited by applicant]
“U.S. Appl. No. 15/687,925, Non Final Office Action mailed Jun. 11, 2019”, 11 pgs. [cited by applicant]
“U.S. Appl. No. 15/687,925, Non Final Office Action mailed Oct. 9, 2018”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 15/687,925, Response filed Jan. 9, 2019 to Non Final Office Action mailed Oct. 9, 2018”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 15/687,925, Response filed May 13, 2019 to Final Office Action mailed Feb. 14, 2019”, 11 pgs. [cited by applicant]
“U.S. Appl. No. 15/688,676, Examiner Interview Summary mailed Sep. 25, 2019”, 3 pgs. [cited by applicant]
“U.S. Appl. No. 15/688,676, Final Office Action mailed Jul. 29, 2019”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 15/688,676, Non Final Office Action mailed Jan. 11, 2019”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 15/688,676, Non Final Office Action mailed Oct. 30, 2019”, 6 pgs. [cited by applicant]
“U.S. Appl. No. 15/688,676, Notice of Allowance mailed Apr. 14, 2020”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 15/688,676, Response filed Jan. 7, 2020 to Non Final Office Action mailed Oct. 30, 2019”, 10 pgs. [cited by applicant]
“U.S. Appl. No. 15/688,676, Response filed Sep. 25, 2019 to Final Office Action mailed Jul. 29, 2019”, 10 pgs. [cited by applicant]
“U.S. Appl. No. 15/688,676, Response filed Apr. 9, 2019 to Non Final Office Action mailed Jan. 11, 2019”, 12 pgs. [cited by applicant]
“U.S. Appl. No. 15/711,578, Examiner Interview Summary mailed Aug. 28, 2019”, 3 pgs. [cited by applicant]
“U.S. Appl. No. 15/711,578, Non Final Office Action mailed May 23, 2019”, 6 pgs. [cited by applicant]
“U.S. Appl. No. 15/711,578, Notice of Allowance mailed Nov. 25, 2019”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 15/711,578, Repsonse filed Aug. 23, 2019 to Non Final Office Action mailed May 23, 2019”, 11 pgs. [cited by applicant]
“U.S. Appl. No. 15/711,578, Supplemental Response filed Aug. 28, 2019 to Non Final Office Action mailed May 23, 2019”, 11 pgs. [cited by applicant]
“U.S. Appl. No. 15/788,403, 312 Amendment filed Apr. 22, 2020”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 15/788,403, Corrected Notice of Allowability mailed Mar. 18, 2020”, 2 pgs. [cited by applicant]
“U.S. Appl. No. 15/788,403, Non Final Office Action mailed Jul. 23, 2019”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 15/788,403, Notice of Allowance mailed Jan. 23, 2020”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 15/788,403, PTO Response to Rule 312 Communication mailed Apr. 30, 2020”, 2 pgs. [cited by applicant]
“U.S. Appl. No. 15/788,403, Response filed Oct. 8, 2019 to Non Final Office Action mailed Jul. 23, 2019”, 11 pgs. [cited by applicant]
“U.S. Appl. No. 15/867,756, Examiner Interview Summary mailed Aug. 28, 2019”, 3 pgs. [cited by applicant]
“U.S. Appl. No. 15/867,756, Non Final Office Action mailed Jul. 1, 2019”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 15/867,756, Notice of Allowance mailed Dec. 19, 2019”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 15/867,756, Response filed Aug. 29, 2019 to Non Final Office Action mailed Jul. 1, 2019”, 11 pgs. [cited by applicant]
“U.S. Appl. No. 15/867,760, Examiner Interview Summary mailed Aug. 28, 2019”, 3 pgs. [cited by applicant]
“U.S. Appl. No. 15/867,760, Non Final Office Action mailed Jul. 1, 2019”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 15/867,760, Notice of Allowance mailed Dec. 19, 2019”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 15/867,760, Response filed Aug. 29, 2019 to Non-Final Office Action mailed Jul. 1, 2019”, 11 pgs. [cited by applicant]
“U.S. Appl. No. 15/867,767, Non Final Office Action mailed Dec. 17, 2019”, 11 pgs. [cited by applicant]
“U.S. Appl. No. 15/867,767, Notice of Allowance mailed Apr. 6, 2020”, 5 pgs. [cited by applicant]
“U.S. Appl. No. 15/867,767, Response filed Mar. 4, 2020 to Non Final Office Action mailed Dec. 17, 2019”, 10 pgs. [cited by applicant]
“U.S. Appl. No. 15/867,772, Advisory Action mailed Dec. 22, 2020”, 3 pgs. [cited by applicant]
“U.S. Appl. No. 15/867,772, Examiner Interview Summary mailed Apr. 29, 2021”, 2 pgs. [cited by applicant]
“U.S. Appl. No. 15/867,772, Examiner Interview Summary mailed Dec. 11, 2020”, 2 pgs. [cited by applicant]
“U.S. Appl. No. 15/867,772, Final Office Action mailed Oct. 22, 2020”, 10 pgs. [cited by applicant]
“U.S. Appl. No. 15/867,772, Non Final Office Action mailed Apr. 2, 2020”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 15/867,772, Notice of Allowance mailed Apr. 23, 2021”, 5 pgs. [cited by applicant]
“U.S. Appl. No. 15/867,772, Response filed Jun. 30, 2020 to Non Final Office Action mailed Apr. 2, 2020”, 10 pgs. [cited by applicant]
“U.S. Appl. No. 15/867,772, Response filed Dec. 15, 2020 to Final Office Action mailed Oct. 22, 2020”, 12 pgs. [cited by applicant]
“U.S. Appl. No. 15/867,789, Non Final Office Action mailed Apr. 2, 2020”, 10 pgs. [cited by applicant]
“U.S. Appl. No. 15/867,801, Non Final Office Action mailed Sep. 30, 2019”, 10 pgs. [cited by applicant]
“U.S. Appl. No. 15/867,801, Notice of Allowance mailed Feb. 5, 2020”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 15/867,801, Response filed Dec. 18, 2019 to Non Final Office Action mailed Sep. 30, 2019”, 12 pgs. [cited by applicant]
“U.S. Appl. No. 15/867,873, Non Final Office Action mailed Apr. 3, 2020”, 11 pgs. [cited by applicant]
“U.S. Appl. No. 15/867,873, Notice of Allowance mailed Oct. 22, 2020”, 5 pgs. [cited by applicant]
“U.S. Appl. No. 15/867,873, Response filed Jun. 30, 2020 to Non Final Office Action mailed Apr. 1, 2020”, 10 pgs. [cited by applicant]
“U.S. Appl. No. 15/888,808, Advisory Action mailed Feb. 10, 2020”, 2 pgs. [cited by applicant]
“U.S. Appl. No. 15/888,808, Examiner Interview Summary mailed Aug. 3, 2020”, 3 pgs. [cited by applicant]
“U.S. Appl. No. 15/888,808, Examiner Interview Summary mailed Nov. 21, 2019”, 3 pgs. [cited by applicant]
“U.S. Appl. No. 15/888,808, Final Office Action mailed Dec. 16, 2019”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 15/888,808, Non Final Office Action mailed Jul. 2, 2020”, 11 pgs. [cited by applicant]
“U.S. Appl. No. 15/888,808, Non Final Office Action mailed Sep. 11, 2019”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 15/888,808, Notice of Allowance mailed Nov. 30, 2020”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 15/888,808, Response filed Jan. 31, 2020 to Final Office Action mailed Dec. 16, 2019”, 11 pgs. [cited by applicant]
“U.S. Appl. No. 15/888,808, Response filed Mar. 16, 2020 to Advisory Action mailed Feb. 10, 2020”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 15/888,808, Response filed Sep. 29, 2020 to Non Final Office Action mailed Jul. 2, 2020”, 11 pgs. [cited by applicant]
“U.S. Appl. No. 15/888,808, Response filed Nov. 19, 2019 to Non Final Office Action mailed Sep. 11, 2019”, 10 pgs. [cited by applicant]
“U.S. Appl. No. 16/034,304, Examiner Interview Summary mailed Sep. 15, 2020”, 3 pgs. [cited by applicant]
“U.S. Appl. No. 16/034,304, Final Office Action mailed Jul. 27, 2020”, 11 pgs. [cited by applicant]
“U.S. Appl. No. 16/034,304, Non Final Office Action mailed Apr. 3, 2020”, 15 pgs. [cited by applicant]
“U.S. Appl. No. 16/034,304, Notice of Allowance mailed Sep. 29, 2020”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 16/034,304, Response filed Jun. 30, 2020 to Non Final Office Action mailed Apr. 3, 2020”, 13 pgs. [cited by applicant]
“U.S. Appl. No. 16/034,304, Response filed Sep. 16, 2020 to Final Office Action mailed Jul. 27, 2020”, 11 pgs. [cited by applicant]
“U.S. Appl. No. 16/800,822, Non Final Office Action mailed Nov. 29, 2021”, 5 pgs. [cited by applicant]
“U.S. Appl. No. 16/800,822, Notice of Allowance mailed May 18, 2022”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 16/800,822, Response filed Feb. 3, 2022 to Non Final Office Action mailed Nov. 29, 2021”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 16/820,474, Corrected Notice of Allowability mailed Feb. 9, 2022”, 2 pgs. [cited by applicant]
“U.S. Appl. No. 16/820,474, Non Final Office Action mailed Oct. 12, 2021”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 16/820,474, Notice of Allowance mailed Jan. 25, 2022”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 16/820,474, Response filed Dec. 16, 2021 to Non Final Office Action mailed Oct. 12, 2021”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 16/821,161, Non Final Office Action mailed Jan. 3, 2022”, 5 pgs. [cited by applicant]
“U.S. Appl. No. 16/821,161, Notice of Allowance mailed Apr. 4, 2022”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 16/821,161, Response filed Jan. 27, 2022 to Non Final Office Action mailed Jan. 3, 2022”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 16/848,580, Examiner Interview Summary mailed Feb. 4, 2022”, 3 pgs. [cited by applicant]
“U.S. Appl. No. 16/848,580, Examiner Interview Summary mailed Jun. 29, 2022”, 2 pgs. [cited by applicant]
“U.S. Appl. No. 16/848,580, Final Office Action mailed May 10, 2022”, 17 pgs. [cited by applicant]
“U.S. Appl. No. 16/848,580, Non Final Office Action mailed Jan. 4, 2022”, 14 pgs. [cited by applicant]
“U.S. Appl. No. 16/848,580, Response filed Feb. 2, 2022 to Non Final Office Action mailed Jan. 4, 2022”, 11 pgs. [cited by applicant]
“U.S. Appl. No. 16/848,580, Response filed Jun. 27, 2022 to Final Office Action mailed May 10, 2022”, 12 pgs. [cited by applicant]
“U.S. Appl. No. 16/986,519, Non Final Office Action mailed Oct. 5, 2022”, 11 pgs. [cited by applicant]
“U.S. Appl. No. 16/986,519, Notice of Allowance mailed Apr. 24, 2023”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 16/986,519, Response filed Jan. 4, 2023 to Non Final Office Action mailed Oct. 5, 2022”, 10 pgs. [cited by applicant]
“U.S. Appl. No. 17/095,642, Non Final Office Action mailed Feb. 17, 2022”, 13 pgs. [cited by applicant]
“U.S. Appl. No. 17/095,642, Notice of Allowance mailed May 4, 2022”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 17/095,642, Response filed Mar. 31, 2022 to Non Final Office Action mailed Feb. 17, 2022”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 17/884,794, Examiner Interview Summary mailed Nov. 6, 2023”, 2 pgs. [cited by applicant]
“U.S. Appl. No. 17/884,794, Non Final Office Action mailed Aug. 17, 2023”, 13 pgs. [cited by applicant]
“U.S. Appl. No. 17/884,794, Notice of Allowance mailed Dec. 19, 2023”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 17/884,794, Response filed Nov. 10, 2023 to Non Final Office Action mailed Aug. 17, 2023”, 12 pgs. [cited by applicant]
“Australian Application Serial No. 2017325823, First Examination Report mailed Jun. 19, 2019”, 3 pgs. [cited by applicant]
“Australian Application Serial No. 2017334841, First Examination Report mailed Jun. 24, 2019”, 3 pgs. [cited by applicant]
“Australian Application Serial No. 2017334841, Response filed Feb. 6, 2020 to First Examination Report mailed Jun. 24, 2019”, 14 pgs. [cited by applicant]
“Australian Application Serial No. 2017335497, First Examination Report mailed Jun. 26, 2019”, 3 pgs. [cited by applicant]
“Australian Application Serial No. 2017335497, Response filed Nov. 27, 2019 to First Examination Report mailed Jun. 26, 2019”, 18 pgs. [cited by applicant]
“Australian Application Serial No. 2018304079, First Examination Report mailed Jun. 11, 2020”, 5 pgs. [cited by applicant]
“Australian Application Serial No. 2018304079, Response filed Oct. 29, 2020 to First Examination Report mailed Jun. 11, 2020”, 14 pgs. [cited by applicant]
“European Application Serial No. 17762308.9, Response to Communication pursuant to Rules 161 & 162 filed Nov. 26, 2019”, 23 pgs. [cited by applicant]
“European Application Serial No. 17778108.5, Response to Communication Pursuant to Rules 161 and 162 filed Dec. 2, 2019”, 3 pgs. [cited by applicant]
“European Application Serial No. 17794503.7, Response to Communication Pursuant to Rules 161 and 162 filed Dec. 30, 2019”, 11 pgs. [cited by applicant]
“European Application Serial No. 18701908.8, Communication Pursuant to Article 94(3) EPC mailed May 20, 2020”, 6 pgs. [cited by applicant]
“European Application Serial No. 18701908.8, Response filed Sep. 29, 2020 to Communication Pursuant to Article 94(3) EPC mailed May 20, 2020”, 29 pgs. [cited by applicant]
“European Application Serial No. 18701908.8, Response to Communication Pursuant to Rules 161 and 162 filed Mar. 16, 2020”, 8 pgs. [cited by applicant]
“European Application Serial No. 18702012.8, Response to Communication Pursuant to Rules 161 and 162 filed Mar. 11, 2020”, 12 pgs. [cited by applicant]
“European Application Serial No. 18704105.8, Communication Pursuant to Article 94(3) EPC mailed Jan. 5, 2022”, 9 pgs. [cited by applicant]
“European Application Serial No. 18704105.8, Response filed May 6, 2022 to Communication Pursuant to Article 94(3) EPC mailed Jan. 5, 2022”, 35 pgs. [cited by applicant]
“European Application Serial No. 18704105.8, Response to Communication Pursuant to Rules 161 and 162 filed Feb. 27, 2020”, 10 pgs. [cited by applicant]
“European Application Serial No. 21188652.8, Extended European Search Report mailed Nov. 24, 2021”, 9 pgs. [cited by applicant]
“European Application Serial No. 21188652.8, Response filed Jul. 4, 2022 to Extended European Search Report mailed Nov. 24, 2021”, 10 pgs. [cited by applicant]
“European Application Serial No. 21189952.1, Extended European Search Report mailed Nov. 22, 2021”, 7 pgs. [cited by applicant]
“International Application Serial No. PCT/US2017/048867, International Preliminary Report on Patentability mailed Mar. 28, 2019”, 8 pgs. [cited by applicant]
“International Application Serial No. PCT/US2017/048867, International Search Report mailed Nov. 13, 2017”, 5 pgs. [cited by applicant]
“International Application Serial No. PCT/US2017/048867, Written Opinion mailed Nov. 13, 2017”, 6 pgs. [cited by applicant]
“International Application Serial No. PCT/US2017/048896, International Preliminary Report on Patentability mailed Apr. 11, 2019”, 8 pgs. [cited by applicant]
“International Application Serial No. PCT/US2017/048896, International Search Report mailed Nov. 27, 2017”, 5 pgs. [cited by applicant]
“International Application Serial No. PCT/US2017/048896, Written Opinion mailed Nov. 27, 2017”, 6 pgs. [cited by applicant]
“International Application Serial No. PCT/US2017/052685, International Preliminary Report on Patentability mailed Apr. 11, 2019”, 6 pgs. [cited by applicant]
“International Application Serial No. PCT/US2017/052685, International Search Report mailed Jan. 4, 2018”, 5 pgs. [cited by applicant]
“International Application Serial No. PCT/US2017/052685, Written Opinion mailed Jan. 4, 2018”, 6 pgs. [cited by applicant]
“International Application Serial No. PCT/US2017/057367, International Preliminary Report on Patentability mailed May 9, 2019”, 6 pgs. [cited by applicant]
“International Application Serial No. PCT/US2017/057367, International Search Report mailed Jan. 19, 2018”, 4 pgs. [cited by applicant]
“International Application Serial No. PCT/US2017/057367, Written Opinion mailed Jan. 19, 2018”, 4 pgs. [cited by applicant]
“International Application Serial No. PCT/US2018/013251, International Preliminary Report on Patentability mailed Jul. 25, 2019”, 7 pgs. [cited by applicant]
“International Application Serial No. PCT/US2018/013251, International Search Report mailed Apr. 12, 2018”, 4 pgs. [cited by applicant]
“International Application Serial No. PCT/US2018/013251, Written Opinion mailed Apr. 12, 2018”, 5 pgs. [cited by applicant]
“International Application Serial No. PCT/US2018/013257, International Preliminary Report on Patentability mailed Jul. 25, 2019”, 8 pgs. [cited by applicant]
“International Application Serial No. PCT/US2018/013257, International Search Report mailed Apr. 19, 2018”, 4 pgs. [cited by applicant]
“International Application Serial No. PCT/US2018/013257, Written Opinion mailed Apr. 19, 2018”, 6 pgs. [cited by applicant]
“International Application Serial No. PCT/US2018/013268, International Preliminary Report on Patentability mailed Jul. 25, 2019”, 13 pgs. [cited by applicant]
“International Application Serial No. PCT/US2018/013268, International Search Report mailed Apr. 30, 2018”, 5 pgs. [cited by applicant]
“International Application Serial No. PCT/US2018/013268, Written Opinion mailed Apr. 30, 2018”, 11 pgs. [cited by applicant]
“International Application Serial No. PCT/US2018/041860, International Preliminary Report on Patentability mailed Jan. 30, 2020”, 7 pgs. [cited by applicant]
“International Application Serial No. PCT/US2018/041860, International Search Report mailed Oct. 17, 2018”, 4 pgs. [cited by applicant]
“International Application Serial No. PCT/US2018/041860, Written Opinion mailed Oct. 17, 2018”, 5 pgs. [cited by applicant]
Ahern, David K., et al., “Comparison of lumbar paravertebral EMG patterns in chronic low back pain patients and non-patient controls”, Pain, 34, (1988), 153-160. [cited by applicant]
Allum, John H.J., et al., “A speedy solution for balance and gait analysis: angular velocity measured at the centre of body mass”, Current Opinion in Neurology 18, (2005), 15-21. [cited by applicant]
Alo, Kenneth M., et al., “Effect of Spinal Cord Stimulation on Sensory Nerve Conduction Threshold Functional Measures”, Neuromodulation, vol. 3, No. 3, (2000), 145-154. [cited by applicant]
Ambady, Nalini, et al., “Thin Slices of Expressive Behavior as Predictors of Interpersonal Consequences: A Meta-Analysis”, Psychological Bulletin, 1992, vol. 111, No. 2, 256-274. [cited by applicant]
Annoni, Elizabeth M., et al., “Method and Apparatus for Pain Management Using Objective Pain Measure”, U.S. Appl. No. 62/400,336, filed Sep. 27, 2016. [cited by applicant]
Annoni, Elizabeth M., et al., “Pain Management Based on Brain Activity Monitoring”, U.S. Appl. No. 62/445,061, filed Jan. 11, 2017. [cited by applicant]
Annoni, Elizabeth M., et al., “Pain Management Based on Muscle Tension Measurements”, U.S. Appl. No. 62/445,092, filed Jan. 11, 2017. [cited by applicant]
Annoni, Elizabeth M., et al., “Pain Management Based on Respiration-Mediated Heart Rates”, U.S. Appl. No. 62/445,069, filed Jan. 11, 2017. [cited by applicant]
Annoni, Elizabeth M., et al., “Patient-Specific Calibration of Pain Quantification”, U.S. Appl. No. 62/445,095, filed Jan. 11, 2017. [cited by applicant]
Arsenault, Marianne, et al., “Pain Modulation Induced by Respiration: Phase and Frequency Effects”, Neuroscience 252, (2013), 501-511. [cited by applicant]
Artner, Juraj, et al., “Prevalence of sleep deprivation in patients with chronic neck and back pain: a retrospective evaluation of 1016 patients”, Journal of Pain Research: 6, (2013), 1-6. [cited by applicant]
Ashraf, A B, et al., “The painful face—Pain expression recognition using active appearance models”, Image and Vision Computing Elsevier Guildford, GB, vol. 27, No. 12, (Nov. 1, 2009), 1788-1796. [cited by applicant]
Bakker, Jorn, et al., “What's your current stress level? Detection of stress patterns from GSR sensor data”, Eindhoven University of Technology—The Netherlands, (2011), 1-8. [cited by applicant]
Baliki, Marwan N., et al., “Beyond Feeling: Chronic Pain hurts the Brain, Disrupting the Default-Mode Network Dynamics”, The Journal of Neuroscience, 28 (6), (Feb. 6, 2008), 1398-1403. [cited by applicant]
Banos, Oresti, et al., “PhysioDroid: Combining Wearable Health Sensors and Mobile Devices for a Ubiquitous, Continuous, and Personal Monitoring”, The Scientific World Journal, vol. 2014 Article ID 190824, (2014), 11 pgs. [cited by applicant]
Bansevicius, Dalius, et al., “Mental stress of long duration: EMG activity, perceived tension, fatigue, and pain development in pain-free subjects”, Headache: The Journal of Head and Face Pain; 37.8, (1997), 499-510. [cited by applicant]
Barad, Meredith J., et al., “Complex Regional Pain Syndrome Is Associated With Structural Abnormalities in Pain-Related Regions of the Human Brain”, The Journal of Pain, vol. 15, No. 2, (Feb. 2014), 197-203. [cited by applicant]
Barkley, Jacob E., et al., “The effect of spinal cord stimulation unit revision on perceived pain, anxiety, mobility and physical activity in individuals with low back/lower extremity pain”, Kent State University—The Sp… [cited by applicant]
Bartlett, Marian Stewart, et al., “Automatic Decoding of Facial Movements Reveals Deceptive Pain Expressions”, Current Biology 24, 738-743, Mar. 31, 2014. [cited by applicant]
Beneck, George J., et al., “Spectral analysis of EMG using intramuscular electrodes reveals non-linear fatigability characteristics in persons with chronic low back pain”, Journal of Electromyography and Kinesiology 23,… [cited by applicant]
Ben-Israel, Nir, et al., “Monitoring the nociception level: a multi-parameter approach”, J Clin Monit Comput, (Jul. 2012), 10 pgs. [cited by applicant]
Ben-Israel, Nir, et al., “Monitoring the nociception level: a multi-parameter approach”, J Clin Monit Comput 27, (2013), 659-668. [cited by applicant]
Berthomier, Christian, et al., “Automatic analysis of single-channel sleep EEG: validation in healthy individuals”, Sleep-New York Then Westchester—30.11, (2007), 1587-1595. [cited by applicant]
Boselli, E., et al., “Prediction of immediate postoperative pain using the analgesia/nociception index: a prospective observational study”, British Journal of Anaesthesia 112 (4):, (2014), 715-721. [cited by applicant]
Boselli, E., et al., “Prospective observational study of the non-invasive assessment of immediate postoperative pain using the analgesia/nociception index (ANI)”, British Journal of Anaesthesia 111, (2013), 453-459. [cited by applicant]
Broucqsault-Dedrie, Celine, et al., “Measurement of Heart Rate Variability to Assess Pain in Sedated Critically III Patients: A Prospective Observational Study”, PLOS One, (Jan. 25, 2016), 1-11. [cited by applicant]
Bunde, Armin, et al., “Correlated and uncorrelated regions in heart-rate fluctuations during sleep”, Physical Review Letters 85.17, (2000), 3736-3739. [cited by applicant]
Chan, C. W.Y., et al., “Subjective pain sensation is linearly correlated with the Flexion reflex in man”, Brain Research, 479, (1989), 145-150. [cited by applicant]
Chapman, C. Richard, et al., “Phasic pupil dilation response to noxious stimulation in normal volunteers: relationship to brain evoked potentials and pain report”, (1999), 44-52. [cited by applicant]
Chen, Shuzhen, et al., “The role of the autonomic nervous system in hypertension: a bond graph model study”, Physiological measurement 29.4 (2008): 473, (2008), 473-495. [cited by applicant]
Cheng, Qian, et al., “GaitTrack: Health Monitoring of Body Motion from Spatio-Temporal Parameters of Simple Smart Phones”, The ACM Conference on Bioinformatics, Computational Biology, Biomed Biomedical Informatics (BCB)… [cited by applicant]
Chuang, Chiung-Cheng, et al., “Photoplethysmography variability as an alternative approach to obtain heart rate variability information in chronic pain patient”, J Clin Monit Comput—Published online, (Feb. 24, 2015), 1-… [cited by applicant]
Chung, Ok Y., “Baroreflex sensitivity associated hypoalgesia in healthy states is altered by chronic pain”, Pain 138, (2008), 87-97. [cited by applicant]
Ciampi De Andrade, Daniel, et al., “Neurophysiological assessment of spinal cord stimulation in failed back surgery syndrome”, Pain 150, (2010), 485-491. [cited by applicant]
Cinaz, Burcu, et al., “Monitoring of mental workload levels during an everyday life office-work scenario”, Pers Ubiquit Comput 17, (2013), 229-239. [cited by applicant]
Clark, Bryan Allen, et al., “Pain Management Based on Functional Measurements”, U.S. Appl. No. 62/445,075, filed Jan. 11, 2017. [cited by applicant]
Culic, Ognjen, et al., “Serum activities of adenosine deaminase, dipeptidyl peptidase IV and prolyl endopeptidase in patients with fibromyalgia:diagnostic implications”, Clin Rheumatol 35, (2016), 2565-2571. [cited by applicant]
Dansie, Elizabeth J., et al., “Activity in Adults with Chronic Widespread Pain”, The Journal of Pain—Accepted Manuscript, (2014), 33 pgs. [cited by applicant]
Davydov, Dmitry M., et al., “Cardiovascular activity and chronic pain severity”, Physiology & Behavior 152, 203-216 (2015). [cited by applicant]
De-La-Herran, Alvaro M., et al., “Gait Analysis Methods: An Overview of Wearable and Non-Wearable Systems, Highlighting Clinical Applications”, Sensors 14, (2014), 3362-3394. [cited by applicant]
Denk, Franziska, et al., “Chronic Pain: Emerging Evidence for the Involvement of Epigenetics”, Neuron 73 (3), (2012), 435-444. [cited by applicant]
Duschek, S., “Relationship between baroreceptor cardiac reflex sensitivity and pain experience in normotensive individuals”, International Journal of Psychophysiology 65, (2007), 193-200. [cited by applicant]
Eisenberg, Elon, et al., “Quantitative Sensory Testing for Spinal Cord Stimulation in Patients With Chronic Neuropathic Pain”, (2006), 161-165. [cited by applicant]
Elgendi, Mohamed, “On the analysis of fingertip photoplethysmogram signals”, Current cardiology reviews 8.1, (2012), 14-25. [cited by applicant]
Evans, Subhadr, et al., “Heart rate variability as a biomarker for autonomic nervous system response differences between children with chronic pain and healthy control children”, Journal of Pain Research 3.6, (2013), 44… [cited by applicant]
Fagius, J., et al., “The cold pressor test: effects on sympathetic nerve activity in human muscle and skin nerve fascicles”, Acta physiologica Scandinavica 137.3, (1989), 325-334. [cited by applicant]
Fazalbhoy, Azharuddin, et al., “Individual differences in the cardiovascular responses to tonic muscle pain: parallel increases or decreases in muscle sympathetic nerve activity, blood pressure and heart rate”, Exp Phys… [cited by applicant]
Foo, H., et al., “Brainstem modulation of pain during sleep and waking”, Sleep medicine reviews 7.2, (2003), 145-154. [cited by applicant]
Frederiks, Joost, et al., “Within-subject electrocardiogramences at equal heart rates: role of the autonomic nervous system”, Pflügers Archiv 441.5, (2001), 717-724. [cited by applicant]
Geisser, Michael E., et al., “Pain-Related Fear, Lumbar Flexion, and Dynamic EMG Among Persons With Chronic Musculoskeletal Low Back Pain”, Clin J Pain, vol. 20, No. 2, (Apr. 2004). [cited by applicant]
Generaal, Ellen, et al., “Reduced hypothalamic-pituitary-adrenal axis activity in chronic multi-site musculoskeletal pain: partly masked by depressive and anxiety disorders”, BMC Musculoskeletal Disorders, 15:227, (2014… [cited by applicant]
Gesche, Heiko, et al., “Continuous blood pressure measurement by using the pulse transit time: comparison to a cuff-based method”, European journal of applied physiology 112.1, (2012), 309-315. [cited by applicant]
Godfrey, A., et al., “Direct measurement of human movement by accelerometry”, Medical Engineering & Physics 30 (2008) 1364-1386. [cited by applicant]
Godfrey, A., et al., “Instrumenting gait with an accelerometer: a system and algorithm examination”, Medical Engineering & Physics, Mar. 2015, doi:10.1016/j.medengphy.2015.02.003, 24 pgs. [cited by applicant]
Gouveia, S., et al., “Assessing Baroreflex Sensitivity in the Sequences Technique: Local versus Global Approach”, Computers in Cardiology, 32, (2005), 279-282. [cited by applicant]
Granovsky, Yelena, et al., “Objective Correlate of Subjective Pain Perception by Contact Heat-Evoked Potentials”, The Journal of Pain, vol. 9, No. 1, (Jan. 2008), 53-63. [cited by applicant]
Green, Alexande L., “Measurement of muscle sympathetic nerve activity reveals true sympathetic changes in chronic pain”, Exp Physiol 97.10, (2012), 1083. [cited by applicant]
Hallman, David, et al., “Autonomic regulation, physical activity and perceived stress in subjects with musculoskeletal pain: 24-hour ambulatory monitoring”, International Journal of Psychophysiology 86, (2012), 276-282. [cited by applicant]
Hallman, David M., et al., “Changes in physical activity and heart rate variability in chronic neck-shoulder pain: monitoring during work and leisure time”, Int Arch Occup Environ Health 87, (2014), 735-744. [cited by applicant]
Hallman, David M., et al., “Long-Term Monitoring of Physical Behavior Reveals Different Cardiac Responses to Physical Activity among Subjects with and without Chronic Neck Pain”, BioMed Research International, vol. 2015… [cited by applicant]
Hartwich, Doreen, et al., “Effect of muscle metaboreflex activation on spontaneous cardiac baroreflex sensitivity during exercise in humans”, J Physiol 589.24, (2011), 6157- 6171. [cited by applicant]
Jensen, MP, et al., “Brain EEG activity correlates of chronic pain in persons with spinal cord injury: clinical implications”, Nature; Spinal Cord; 51, (Jul. 17, 2012), 55-58. [cited by applicant]
Jess, Gunnar, et al., “Monitoring heart rate variability to assess experimentally induced pain using the analgesia nociception index—A randomised volunteer study”, Eur J Anaesthesiol 32, (2015), 1-8. [cited by applicant]
Kang, Jon-Eun, et al., “Pulse transit time shows vascular changes caused by propofol in children”, J Clin Monit Comput 29, (2015), 533-537. [cited by applicant]
Keefe, Francis J,, et al., “An Objective Approach to Quantifing Pain Behavior and Gait Patterns in Low Back Pain Patients”, Pain, 21, (1985), 153-161. [cited by applicant]
Kemler, Marius A., et al., “Impact of Spinal Cord Stimulation on Sensory Characteristics in Complex Regional Pain Syndrome Type 1—A Randomized Trial”, Anesthesiology, 95, (2001), 72-80. [cited by applicant]
Keshari, Kayvan R., et al., “Lactic Acid and Proteoglycans as Metabolic Markers dor Discogenic Back Pain”, Spine, vol. 13, No. 3, (2008), 312-317. [cited by applicant]
Kim, Young Uk, et al., “Pulse Transit Time as a Predictor of the Efficacy of a Celiac Plexus Block in Patients With Chronic Intractable Abdominal Pain”, Clin J Pain, vol. 32, No. 6, (Jun. 2015), 522-526. [cited by applicant]
Kodituwakku, Sandun, et al., “Point Process Respiratory Sinus Arrhythmia Analysis during Deep Tissue Pain Stimulation”, Computing in Cardiology 38, (2011), 193-196. [cited by applicant]
Koenig, J., et al., “Heart rate variability and experimentally induced pain in healthy adults: A systematic review”, European Journal of Pain 18, (2014), 301-314. [cited by applicant]
Koenig, Julian, et al., “Chronic Pain and Heart Rate Variability in a Cross-Sectional Occupational Sample Evidence for Impaired Vagal Control”, The Clinical Journal of Pain, Publish Ahead of Print, (2015), 31 pgs. [cited by applicant]
La Rovere, Maria Teresa, et al., “Baroreflex Sensitivity: Measurement and Clinical Implications”, Ann Noninvasive Electrodardiol, 13(2):191-207, 2008. [cited by applicant]
Lamoth, Claudine J.C., et al., “How do persons with chronic low back pain speed up and slow down? Trunk-pelvis coordination and erector spinae activity during gait”, Gait & Posture 23, (2006), 230-239. [cited by applicant]
Lamoth, Claudine J.C., et al., “Pelvis-Thorax Coordination in the Transverse Plane During Walking in Persons With Nonspecific Low Back Pain”, Spine, vol. 27, No. 4, (2002), E92-E99. [cited by applicant]